Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular MechanismsZheng Zhou, Na Qin, Fernando García-Alcalde et al.|Scientific Reports|2017Cited by 150
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Wei Zhu, Xianfeng Lin et al.|Journal of Medicinal Chemistry|2017Cited by 59